Effect of Cardiac Resynchronization Therapy on Pulmonary Function in Patients With Heart Failure

被引:10
|
作者
Cundrle, Ivan, Jr. [1 ,2 ]
Johnson, Bruce D. [2 ]
Somers, Virend K. [2 ]
Scott, Christopher G. [3 ]
Rea, Robert F. [2 ]
Olson, Lyle J. [2 ]
机构
[1] St Annas Univ Hosp, Dept Anesthesiol & Intens Care, Int Clin Res Ctr, Brno, Czech Republic
[2] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 112卷 / 06期
关键词
INTERSTITIAL LUNG-DISEASE; AIRWAY-OBSTRUCTION; SLEEP-APNEA; HYPERTENSION; EXERCISE; IMPROVEMENT; MANAGEMENT; DIAGNOSIS; CAPACITY; PATTERN;
D O I
10.1016/j.amjcard.2013.05.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary congestion due to heart failure causes abnormal lung function. Cardiac resynchronization therapy (CRT) is a proven effective treatment for heart failure. The aim of this study was to test the hypothesis that CRT promotes increased lung volumes, bronchial conductance, and gas diffusion. Forty-four consecutive patients with heart failure were prospectively investigated before and after CRT. Spirometry, gas diffusion (diffusing capacity for carbon monoxide), cardiopulmonary exercise testing, New York Heart Association class, brain natriuretic peptide, the left ventricular ejection fraction, left atrial volume, and right ventricular systolic pressure were assessed before and 4 to 6 months after CRT. Pre- and post-CRT measures were compared using either paired Student's t tests or Wilcoxon's matched-pair test; p values <0.05 were considered significant. Improved New York Heart Association class, left ventricular ejection fraction, left atrial volume, right ventricular systolic pressure, and brain natriuretic peptide were observed after CRT (p <0.05 for all). Spirometry after CRT demonstrated increased percentage predicted total lung capacity (90, 17% vs 96 +/- 15%, p <0.01) and percentage predicted forced vital capacity (80 +/- 19% vs 90 +/- 19%, p <0.01). Increased percentage predicted total lung capacity was significantly correlated with increased peak exercise end-tidal carbon dioxide (r = 0.43, p = 0.05). Increased percentage predicted forced vital capacity was significantly correlated with decreased right ventricular systolic pressure (r = 0.30, p = 0.05), body mass index (r = 0.35, p = 0.02) and creatinine (r = 0.49, p = 0.02), consistent with an association of improved bronchial conductance and decreased congestion. Diffusing capacity for carbon monoxide did not significantly change. In conclusion, increased lung volumes and bronchial conductance due to decreased pulmonary congestion and increased intrathoracic space contribute to an improved breathing pattern and decreased hyperventilation after CRT. Persistent alveolar-capillary membrane remodeling may account for unchanged diffusing capacity for carbon monoxide. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:838 / 842
页数:5
相关论文
共 50 条
  • [31] Effect of cardiac resynchronization therapy in the treatment of chronic heart failure
    Kuznetsov, VA
    Kolunin, GV
    Kharats, VE
    Krinotchkin, DV
    Gorbunova, TY
    Pavlov, AV
    Zyryanov, IP
    Gorbatenko, EA
    KARDIOLOGIYA, 2005, 45 (09) : 29 - 31
  • [32] Cardiac Resynchronization Therapy in Patients with Heart Failure: What is New?
    Palmiero, Giuseppe
    Florio, Maria Teresa
    Rubino, Marta
    Nesti, Martina
    Marchel, Michal
    Russo, Vincenzo
    HEART FAILURE CLINICS, 2021, 17 (02) : 289 - 301
  • [33] Use of cardiac resynchronization therapy in patients hospitalized with heart failure
    Piccini, Jonathan P.
    Hernandez, Adrian F.
    Dai, David
    Thomas, Kevin L.
    Lewis, William R.
    Yancy, Clyde W.
    Peterson, Eric D.
    Fonarow, Gregg C.
    CIRCULATION, 2008, 118 (09) : 926 - 933
  • [34] Response to cardiac resynchronization therapy in cancer patients with heart failure
    Silva, B. V.
    Magalhaes, A.
    Menezes, M. Nobre
    Gregorio, C.
    Costa, P.
    Da Silva, P. Alves
    Brito, J.
    Garcia, B.
    Martins, A. M.
    Raposo, M.
    Marques, P.
    Sousa, J.
    Fiuza, M.
    Pinto, F. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 412 - 413
  • [35] Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
    Gasparini, Maurizio
    Regoli, Francois
    Galimberti, Paola
    Ceriotti, Carto
    Cappetteri, Atessio
    EUROPACE, 2009, 11 : 82 - 86
  • [36] PREDICTORS OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH HEART FAILURE
    Stavtseva, Y.
    Villevalde, S.
    Vorobiev, A.
    Sveshnikov, A.
    Kobalaba, Z.
    JOURNAL OF HYPERTENSION, 2015, 33 : E333 - E333
  • [37] Cardiac Resynchronization Therapy (CRT) in Patients with milder Heart Failure
    Korte, Thomas
    HERZ, 2011, 36 (07) : 643 - 644
  • [38] Optimized cardiac resynchronization therapy in patients with congestive heart failure
    NIU Hongxia HUA Wei ZHANG Shu SUN Xin CHEN Keping WANG Fangzheng CHEN Xin Center of Arrhythmia Diagnosis and TreatmentFuwai Hospital and Cardiovascular InstituteChinese Academy and Medical Sciences Peking Union Medical CollegeBeiiing China
    Chinese Medical Journal, 2007, 120 (07) : 605 - 607
  • [39] Cardiac resynchronization therapy in patients with minimally symptomatic heart failure
    Venkataraman, Ganesh
    Strickberger, S. Adam
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (07) : 959 - 963
  • [40] Devices in patients with heart failure. Cardiac resynchronization therapy
    Manuel, Juan, Sr.
    Ramirez, Nelson Dario Giraldo
    IATREIA, 2016, 29 : S160 - S188